Centessa Pharmaceuticals ^Public

Centessa Pharmaceuticals is a next-generation biopharmaceutical company that aims to reshape the traditional drug development process. The company applies an asset-centric R&D model at scale to advance a portfolio of highly validated programs led by industry-leading teams. Each program is developed by a Centessa Subsidiary and supported by a centralized infrastructure and the Centessa management team. Centessa Pharmaceuticals is focused on developing transformative treatment options for patients with sleep-wake disorders and hemophilia B, with potential expansion into other bleeding disorders.